BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2401129)

  • 1. Comparative effects of diltiazem sustained-release formulation and metoprolol on ambulatory blood pressure and plasma lipoproteins.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    Clin Pharmacol Ther; 1990 Sep; 48(3):318-24. PubMed ID: 2401129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diltiazem compared with metoprolol as add-on-therapies to diuretics in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
    Thulin T; Hedner T; Gustafsson S; Olsson SO
    J Hum Hypertens; 1991 Apr; 5(2):107-14. PubMed ID: 2072368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of diltiazem and metoprolol in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
    Hedner T; Thulin T; Gustafsson S; Olsson SO
    Eur J Clin Pharmacol; 1990; 39(5):427-33. PubMed ID: 2076733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release diltiazem: duration of antihypertensive effect.
    Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; Dipette DJ; Evans RR
    J Clin Pharmacol; 1989 Jun; 29(6):533-7. PubMed ID: 2666454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris.
    Vliegen HW; van der Wall EE; Niemeyer MG; Holwerda NJ; Bernink PJ; de Weerd P; Bosma AH; van der Wieken LR; Timmermans AJ; Molhoek GP
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S55-60. PubMed ID: 1725545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
    Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H
    Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diltiazem in the treatment of mild or moderate essential hypertension. Comparison with metoprolol in a crossover double-blind trial.
    Trimarco B; DeLuca N; Ricciardelli B; Volpe M; Veniero A; Cuocolo A; Cicala M
    J Clin Pharmacol; 1984; 24(5-6):218-27. PubMed ID: 6378988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group.
    Dahlöf C; Hedner T; Thulin T; Gustafsson S; Olsson SO
    Eur J Clin Pharmacol; 1991; 40(5):453-60. PubMed ID: 1884720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of once-daily atenolol and metoprolol using office and ambulatory blood pressure monitoring.
    Rutan GH; Feig PU; May S; Kriegman AG; Brady EM
    J Clin Pharmacol; 1993 May; 33(5):418-26. PubMed ID: 8331198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
    Pool PE; Seagren SC; Salel AF
    Am J Cardiol; 1985 Dec; 56(16):86H-91H. PubMed ID: 3907322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained antihypertensive activity of diltiazem SR: double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring.
    Whelton A; Eff J; Magner DJ
    J Clin Pharmacol; 1992 Sep; 32(9):808-15. PubMed ID: 1430300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol.
    Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW
    Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effect of diltiazem in a slow-release formulation for mild to moderate essential hypertension.
    Nikkilä MT; Inkovaara JA; Heikkinen JT; Olsson SO
    Am J Cardiol; 1989 May; 63(17):1227-30. PubMed ID: 2711992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension.
    Wolfson P; Abernethy D; DiPette DJ; Zusman R
    Am J Cardiol; 1988 Oct; 62(11):103G-108G. PubMed ID: 3051990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of metoprolol and diltiazem in treating silent myocardial ischemia.
    Portegies MC; Sijbring P; Göbel EJ; Viersma JW; Lie KI
    Am J Cardiol; 1994 Dec; 74(11):1095-8. PubMed ID: 7977065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension.
    Dupont AG; Coupez JM; Jensen P; Coupez-Lopinot R; Schoors DF; Hermanns P; Nicolas M
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):701-7. PubMed ID: 1888693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
    Johnston GD; Vyssoulis G; Feely J; Holden RD; Radley DR
    J Hum Hypertens; 1995 Feb; 9(2):123-9. PubMed ID: 7752174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
    Pool PE; Massie BM; Venkataraman K; Hirsch AT; Samant DR; Seagren SC; Gaw J; Salel AF; Tubau JF
    Am J Cardiol; 1986 Feb; 57(4):212-7. PubMed ID: 3511660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.